Trial intelligence / Profile preview

METCAP: Metformin + Neoadjuvant Radiochemotherapy in Rectal Cancer

NCT02437656Phase 2Completed

Sponsor
Centre Oscar Lambret
Start
May 2015
Primary completion
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of metformin in rectal cancer, sponsored by Centre Oscar Lambret. Started May 2015; status: completed.

02

Drugs

metformin
03

Conditions

rectal cancer

Beyond the preview

Go deeper on NCT02437656.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02437656.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call